• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Britain’s antiviral chief hints at interest in Merck COVID-19 pill

October 1, 2021 by David Barret Leave a Comment

October 1, 2021

LONDON (Reuters) -The chair of Britain’s antivirals taskforce declined to comment directly about talks over Merck & Co Inc’s experimental oral COVID-19 drug molnupiravir, but hinted at Britain’s interest in buying the potential breakthrough pill.

Taskforce chair Eddie Gray was speaking to reporters after interim clinical trial results published on Thursday showed molnupiravir reduced the chance of hospitalisation or death for patients at risk of severe disease by about 50%.

“We are involved in looking closely at all of the options available, but we’re really not in a position to give out the details around specific conversations at this moment in time,” he told a briefing about molnupiravir after the results were published, which was also attended by a Merck representative.

Asked in the online briefing when he could give more details, he said: “The emergence of phase III data tends to accelerate all processes of this type, but I couldn’t give you a specific date.”

Speaking alongside Merck’s vice president for infectious diseases discovery, Daria Hazuda, Gray hinted that Britain would look to buy the drug, saying: “I have chosen to turn up today to be here. Read into that what you wish.”

Merck and partner Ridgeback Biotherapeutics plan to seek U.S. emergency use authorisation for the pill as soon as possible, and to submit applications to regulatory agencies worldwide. Due to the positive results, the Phase III trial is being stopped early at the recommendation of outside monitors.

If authorised, molnupiravir, which is designed to introduce errors into the genetic code of the coronavirus, would be the first oral antiviral medication for COVID-19.

“We’re committed to making this drug rapidly available in the UK,” Merck’s Hazuda said.

(Reporting by Alistair Smout; Editing by David Clarke)

Source Link Britain’s antiviral chief hints at interest in Merck COVID-19 pill

David Barret
David Barret

Related posts:

  1. Small U.S. employers frustrated by Biden’s COVID vaccine mandate
  2. Analysis-Epic’s narrow win in App Store case toughens fight against Google Play rules
  3. As Fed readies for taper, Chair Powell convenes listening event
  4. Firefighters retreat as La Palma volcanic explosions intensify

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • If Birds Are Dinosaurs, Why Are None As Big As T. Rexes?
  • Psychologists Demonstrate Illusion That Could Be Screwing Up Our Perception Of Time
  • Why Are So Many Enormous Roman Shoes Being Discovered At Hadrian’s Wall?
  • Scientists Think They’ve Pinpointed Structural Differences In Psychopaths’ Brains
  • We’ve Found Our Third-Ever Interstellar Visitor, Orcas Filmed Kissing (With Tongues) In The Wild, And Much More This Week
  • The “Eyes Of Clavius” Will Be Visible On The Moon Today, Thanks To Clair-Obscur Effect
  • Shockingly High Microplastic Levels Found On Remote Mediterranean Coral Reef Island
  • Interstellar Object, Cheesy Nightmares, And Smooching Orcas
  • World’s Largest Martian Meteorite Up For Auction Could Reach Whopping $2-4 Million
  • Kimalu The Beluga Whale Undergoes Pioneering Surgery And Becomes First Beluga To Survive General Aesthetic
  • The 1986 Soviet Space Mission That’s Never Been Repeated: Mir To Salyut And Back Again
  • Grisly Incident In Yellowstone National Park Shows Just How Dangerous This Vibrant Wilderness Can Be
  • Out Of All Greenhouse Gas Emitters On Earth, One US Organization Takes The Biscuit
  • Overly Ambitious Adder Attempts To Eat Hare 10 Times Its Mass In Gnarly Video
  • How Fast Does A Spacecraft Need To Go To Escape The Solar System?
  • President Trump’s Cuts To USAID Could Result In A “Staggering” 14 Million Avoidable Deaths By 2030
  • Dzo: Hybrids Beasts That Are Perfectly Crafted For Life On Earth’s Highest Mountains
  • “Rarest Event Ever” Had A Half-Life 1 Trillion Times Longer Than The Age Of The Universe – How Did We See It?
  • Meet The Bille, A Self-Righting Tetrahedron That Nobody Was Sure Could Exist
  • Neurogenesis Confirmed: Adult Brains Really Do Make New Hippocampal Neurons
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version